MedPath

Exeltis USA, Inc.

Exeltis USA, Inc. logo
🇺🇸United States
Ownership
Subsidiary
Established
2003-01-01
Employees
101
Market Cap
-
Website
http://www.exeltisusa.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

12

FDA:12

Drug Approvals

Benznidazole

Approval Date
Nov 10, 2023
FDA

Nuvessa

Approval Date
Nov 10, 2023
FDA

Select-OB Plus DHA

Approval Date
Jul 24, 2023
FDA

Vitafol

Approval Date
Mar 14, 2023
FDA

Vitafol Fe Plus

Approval Date
Feb 14, 2023
FDA

Vitafol

Approval Date
Feb 14, 2023
FDA

Tyblume

Approval Date
Feb 12, 2023
FDA

Strovite One

Approval Date
Jan 2, 2023
FDA

Vitafol-OB Plus DHA

Approval Date
Dec 31, 2022
FDA

Vitafol OB

Approval Date
Dec 31, 2022
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.